Erasca (ERAS) Current Leases (2020 - 2026)
Erasca (ERAS) reported Current Leases of $5.3 million for Q1 2026, up 9.6% on a YoY basis from $4.8 million in Q1 2025, and up 3.65% quarter-over-quarter from $5.1 million in Q4 2025.
Erasca (ERAS) Current Leases (2020 - 2026) Analysis & Trends
Erasca has reported Current Leases for 7 years, with the latest figure at $5.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 9.6% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 9.6% YoY), and the FY2025 full-year result was $5.1 million, up 9.68% from the prior year.
- Current Leases for Q1 2026 stood at $5.3 million, up from $5.1 million in the prior quarter.
- The five-year high for Current Leases was $5.3 million in Q1 2026, with the low at $14000.0 in Q1 2022.
- Historically, Current Leases has averaged $3.5 million across 5 years, with a median of $4.1 million in 2024.
- Annual changes were most pronounced in 2022 — Current Leases slumped 77.36% — and 2023, when it soared 22171.43%.
- Erasca's Current Leases stood at $1.3 million in 2022, then jumped by 204.21% to $4.0 million in 2023, then rose by 16.35% to $4.6 million in 2024, then increased by 9.68% to $5.1 million in 2025, then rose by 3.65% to $5.3 million in 2026.
- The last three Current Leases figures came in at $5.3 million (Q1 2026), $5.1 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | 5.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | 4.89 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Sep 30, 2023 | 3.82 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 201,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 285,000.00 |
| Sep 30, 2021 | 864,000.00 |
| Jun 30, 2021 | 888,000.00 |